A detailed history of Clearbridge Investments, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Clearbridge Investments, LLC holds 801,420 shares of NTRA stock, worth $164 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
801,420
Previous 342,242 134.17%
Holding current value
$164 Million
Previous $57.8 Million 123.12%
% of portfolio
0.1%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

BUY
$133.66 - $181.11 $61.4 Million - $83.2 Million
459,178 Added 134.17%
801,420 $129 Million
Q2 2025

Aug 12, 2025

BUY
$132.23 - $171.87 $3.21 Million - $4.17 Million
24,283 Added 7.64%
342,242 $57.8 Million
Q1 2025

May 13, 2025

BUY
$132.63 - $177.0 $3.13 Million - $4.17 Million
23,564 Added 8.0%
317,959 $45 Million
Q4 2024

Feb 12, 2025

BUY
$117.67 - $174.0 $34.6 Million - $51.2 Million
294,395 New
294,395 $46.6 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Clearbridge Investments, LLC Portfolio

Follow Clearbridge Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.